Skip to main content
SpringerLink
Log in
Book cover

Essential Medical Facts Every Clinician Should Know pp 215–235Cite as

Drug Interactions and Adventures in Polypharmacy

  • Chapter
  • First Online:

  • 1374 Accesses

Abstract

The use of two or more drugs simultaneously can be perilous, as shown by the ­following case:

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Taylor RB. Medical wisdom and doctoring: the art of 21st century medicine. New York: Springer, 2010. Chapter 5.

    Book  Google Scholar 

  2. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112–1120.

    Article  PubMed  CAS  Google Scholar 

  3. Block AJ. Revisiting the Libby Zion case. Chest. 1994;105(4):977.

    Article  PubMed  CAS  Google Scholar 

References

  1. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287(3):337–344.

    Article  PubMed  Google Scholar 

  2. Riechelmann RP, Moreira F, Smaletz O, Saad ED. Potential for drug interactions in hospitalized cancer patients. Cancer Chemother Pharmacol. 2005;56(3):286–290.

    Article  PubMed  Google Scholar 

  3. Lima RE, De Bortoli-Cassiani SH. Potential drug interactions in intensive care patients at a teaching hospital. Rev Lat Am Enfermagem. 2009;17(2):222–227.

    Article  PubMed  Google Scholar 

References

  1. Raebel MA, Carroll NM, Andrade SE, et al. Monitoring of drugs with a narrow therapeutic range in ambulatory care. Am J Manag Care. 2006;12(5):268–274.

    PubMed  Google Scholar 

  2. Raoof S, Wollschlager C, Kahn FA. Ciprofloxacin increases serum levels of theophylline. Am J Med. 1987;82(4A):115–118.

    PubMed  CAS  Google Scholar 

  3. Adebayo GI, Coker HAB. Cimetidine inhibition of theophylline elimination: the influence of adult age and the time course. Biopharm Drug Dispos. 2006;8(2):149–158.

    Article  Google Scholar 

  4. Renton KW, Gray JD, Hall RI. Decreased elimination of theophylline after influenza vaccination. Can Med Assoc J. 1980;123(4):288–290.

    PubMed  CAS  Google Scholar 

References

  1. Dickinson BD, Altman RD, Nielson NH, Sterling ML, for the Council on Scientific Affairs, American Medical Association. Obstet Gyn. 2001;98(5):853–860.

    Article  CAS  Google Scholar 

  2. Archer JSM, Archer DF. Oral contraceptives efficacy and antibiotic interaction: a myth debunked. J Am Acad Dermatol. 2002;46(6):917–923.

    Article  PubMed  Google Scholar 

Reference

  1. Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54(10):1516–1523.

    Article  PubMed  Google Scholar 

References

  1. Gladding PA, Webster MW, Farrell HB, Zeng IS, Park R, Ruijne N. The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers. Am J Cardiol. 2008;101(7):1060–1063.

    Article  PubMed  CAS  Google Scholar 

  2. Rimon G, Sidhu RS, Lauver DA, et al. Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1. Proc Natl Acad Sci U S A. 2010;107(1):28–33.

    Article  PubMed  CAS  Google Scholar 

  3. Nainggolan L. Celecoxib could impede effects of low-dose aspirin. Medscape. Available at http://www.medscape.com/viewarticle/714041?src=mpnews&spon=34&uac=95007MG/. Accessed April 12, 2010.

Reference

  1. Phelan KM, Mosholdler AD, Lu S. Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory agents. J Clin Psychiatry. 2003;64(11):1328–1334.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Steinhubl SR, Bhatt DL, Brennan DM. Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding. Ann Intern Med. 2009;150(6):379–386.

    PubMed  Google Scholar 

References

  1. Information for Healthcare Professionals: Update to the labeling of clopidogrel bisulfate (marketed as Plavix) to alert healthcare professionals about a drug interaction with omeprazole (marketed as Prilosec and Prilosec OTC). U.S. Food and Drug Administration. Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm190787.htm/. Accessed April 12, 2010.

  2. Gilard M, Arnaud B, Cornily JC, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole Clopidogrel Aspirin) study. J Am Coll Cardiol. 2008;51(3):256–260.

    Article  PubMed  CAS  Google Scholar 

  3. Ho PM, Maddox TM, Want L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009;301(9):937–944.

    Article  PubMed  CAS  Google Scholar 

  4. Siller-Matula JM, Spiel AO, Lang IM, Kreiner G, Christ G, Jilma B. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. Am Heart J. 2009;157(1):148.e1–e5.

    Article  Google Scholar 

  5. O’Donoghue ML, Braunwald E, Antman EM, et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton pump inhibitor: an analysis of two randomized trials. Lancet. 2009;374(9694):989–997.

    Article  PubMed  Google Scholar 

  6. Laine L, Henneken C. Proton pump inhibitor and clopidogrel interaction: fact or fiction? Am J Gastroenterol. 2009;105(1):34–41.

    Article  PubMed  Google Scholar 

  7. Ray WA, Murray KT, Griffin MR, et al. Outcomes with concurrent use of clopidogrel and proton-pump inhibitor. Ann Intern Med. 2010;152(6):337–345.

    PubMed  Google Scholar 

  8. Rassen JA, Choudhry NK, Avorn J, Schneeweiss S. Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation. 2009;120(23):2322–2329.

    Article  PubMed  CAS  Google Scholar 

References

  1. Reeves RR, Mack JE. Possible dangerous interaction of OxyContin and carisoprodol. Am Fam Phys. 2003;67(11):2273.

    Google Scholar 

  2. Owens C, Pugmire B, Salness T, et al. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data. Clin Ther. 2007;29(10):2222–2225.

    Article  PubMed  Google Scholar 

References

  1. Kelly CM, Juurlink DN, Gomes T, et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ. 2010;340:c693. doi: 10.1136/bmj.c693.

    Article  PubMed  Google Scholar 

  2. Hoskins JM, Carey LA, McLeod HL. CYP2D6 and tamoxifen: DNA matters in breast cancer. Nat Rev Cancer. 2009;9(8):576–586.

    Article  PubMed  CAS  Google Scholar 

  3. Tamoxifen, SSRIs, and breast cancer recurrence. Pharmacology Watch. September, 2009; page 1.

    Google Scholar 

  4. Lash TL, Cronin-Fentin D, Ahern TP, et al. Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen. Acta Oncol. 2010;49(3):305–312.

    Article  PubMed  CAS  Google Scholar 

References

  1. Jiao X, Velez S, Ringstad J, Eyma V, Miller D, Bleiberg M. Myocardial infarction associated with Adderall XR and alcohol use in a young man. J Am Board Fam Med. 2009;22(2):197–201.

    Article  PubMed  Google Scholar 

  2. Rosak J. U.S. regulators puzzled by Canada’s ruling on safety of ADHD drug. Psychiatric News. 2005;40(5):2.

    Google Scholar 

References

  1. ONTARGET Investigators, Yusef S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547–1559.

    Article  Google Scholar 

  2. Mann JF, Schmieder RE, McQueen M, et al (ONTARGET Investigators). Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomized, double-blind controlled trial. Lancet. 2008;372(9638):547–553.

    Article  PubMed  CAS  Google Scholar 

  3. Taylor RB. The clinician’s guide to medical writing. New York: Springer, 2005; page 217.

    Google Scholar 

Reference

  1. Antoniou T, Gomes T, Juurlink DN, et al. Trimethoprim–sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin–angiotensin system. Arch Intern Med. 2010;170(12):1045–1049.

    Article  PubMed  CAS  Google Scholar 

References

  1. Chang JT, Staffa JA, Parks M, Green L. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy. Pharmacoepidemiol Drug Saf. 2004;13(7):417–426.

    Article  PubMed  CAS  Google Scholar 

  2. ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1563–1574.

    Article  Google Scholar 

References

  1. Ridtitid W, Wongnawa M, Mahatthanatrakul W, Raungsri N, Sunbhanich M. Ketoconazole increases plasma concentrations of antimalarial mefloquine in healthy human volunteers. J Clin Pharm Ther. 2005;30:285–290.

    Article  PubMed  CAS  Google Scholar 

  2. Sowunmi A, Adio RA, Oduola AM, Ogundahunsi OA, Salako LA. Acute psychosis after mefloquine: report of six cases. Trop Geogr Med. 1995;47(4):179–180.

    PubMed  CAS  Google Scholar 

  3. Ridtitid W, Wongnawa M, Mahatthanatrakul W, Chaipol P, Sunbhanich M. Effect of rifampin on plasma concentrations of mefloquine in healthy volunteers. J Pharm Pharmacol. 2000;52(10):1265–1269.

    Article  PubMed  CAS  Google Scholar 

References

  1. Zapater P, Reus S, Tello A, Torrus D, Perez-Mateo M, Horga JF. A prospective study of the clarithromycin–digoxin interaction in elderly patients. J Antimicrob Chemother. 2002;50(4):601–606.

    Article  PubMed  CAS  Google Scholar 

  2. Tanaka H, Matsumoto K, Ueno K, Kodama M, Yoneda K, Katayama Y, Miyatake K. Effect of clarithromycin on steady-state digoxin concentrations. Ann Pharmacother. 2003;37(2):178–181.

    Article  PubMed  CAS  Google Scholar 

Reference

  1. Nurnberg HG, Hensley PL, Heiman JR, Croft HA, Debattista C, Paine S. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial. JAMA. 2008;300(4):395–404.

    Article  PubMed  CAS  Google Scholar 

References

  1. Kloner RA, Hutter AM, Emmick JT, Mitchell ML, Denne J, Jackson G. Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol. 2003;42(10):1855–1860.

    Article  PubMed  CAS  Google Scholar 

  2. Tadalafil (Cialis). Epocrates Online. Available at: https://online.epocrates.com/u/10a3560?src=PK/. Accessed March 25, 2010.

Reference

  1. de Leon J, Armstrong SC, Cozza KL. The dosing of atypical antipsychotics. Psychosomatics. 2005;46(3):262–273.

    Article  PubMed  Google Scholar 

Reference

  1. Blier P, Ward HE, Tremblay P, et al. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. Am J Psychiatry. 2010;167(3):281–288.

    Article  PubMed  Google Scholar 

References

  1. Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Int Med. 2005;165:1095–1106.

    Article  CAS  Google Scholar 

  2. Ament PW, Bertolino JG, Liszewski JL. Clinically significant drug interactions. Am Fam Phys. 2000;61:1745–1754.

    CAS  Google Scholar 

  3. Gardner P, Phillips R, Shaughnessy AF. Herbal and dietary supplements: drug interactions in patients with chronic illnesses. Am Fam Phys. 2008;77(1):73–78.

    Google Scholar 

  4. Grant P. Warfarin and cranberry juice: an interaction? J Heart Valve Dis. 2004;13(1):25–26.

    PubMed  Google Scholar 

  5. Suvarna R, Pirmohamed M, Henderson L. Possible interaction between warfarin and cranberry juice. BMJ. 2003;327(7429):1454.

    Article  PubMed  Google Scholar 

  6. Buckley MS, Goff AD, Knapp WE. Fish oil interaction with warfarin. Ann Pharmacother. 2004;38(1):50–52.

    Article  PubMed  Google Scholar 

  7. Schelleman H, Bilker WB, Brensinger CM, et al. Fibrate/statin initiation in warfarin users and gastrointestinal bleeding risk. Am J Med. 2010;123(2);151–157.

    Article  PubMed  CAS  Google Scholar 

  8. Fischer HD, Juurlink DN, Mamdani MM, Koop A, Laupacis A. Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study. Arch Intern Med. 2010;170(7):617–621.

    Article  PubMed  CAS  Google Scholar 

  9. Jiang X, Williams KM, Liauw WS, et al. Effect of St John’s wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol. 2004;57(5):592–599.

    Article  PubMed  CAS  Google Scholar 

  10. Taylor RB. White coat tales – medicine’s heroes, heritage and misadventures. New York: Springer, 2008; page 62.

    Google Scholar 

References

  1. Andrén L, Andreasson A, Eggertsen R. Interaction between a commercially available St. John’s wort product (Movina) and atorvastatin in patients with hypercholesterolemia. Eur J Clin Pharmacol. 2007;63(10):913–916.

    Article  PubMed  Google Scholar 

  2. McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. CMAJ. 1996;155(3):293–295.

    PubMed  CAS  Google Scholar 

  3. Gardner P, Phillips R, Shaughnessy AF. Herbal and dietary supplements: drug interactions in patients with chronic illnesses. Am Fam Phys. 2008;77(1):73–78.

    Google Scholar 

References

  1. Kale-Pradhan PB, Jassai HD, Wilhelm SM. Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis. Pharmacotherapy. 2010;30(2):119–129.

    Article  PubMed  Google Scholar 

  2. Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2005;21(5):583–590.

    Article  PubMed  CAS  Google Scholar 

  3. Hickson M, D’Souza AL, Muthu N. Use of probiotic Lactobacillus preparation to prevent diarrhea associated the antibiotics: randomized double blind placebo controlled trial. BMJ. 2007;335(7610):80.

    Article  PubMed  Google Scholar 

References

  1. Fuhr U. Drug interactions with grapefruit juice: extent, probable mechanism and clinical ­relevance. Drug Safety. 1998;18(4):251–272.

    Article  PubMed  CAS  Google Scholar 

  2. Arayne MS, Sultana N, Bibi Z. Grapefruit juice–drug interactions. Pak J Pharm Sci. 2005;18(4):45–57.

    PubMed  CAS  Google Scholar 

  3. Bailey DG, Malcolm J, Arnold O, Spence JD. Grapefruit juice–drug interactions. Br J Clin Pharmacol. 1998;46(2):101–110.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine School of Medicine, Oregon Health & Sciences University, 3181 SW Sam Jackson Park Road, Portland, Oregon, 97239, USA

    Robert B. Taylor

Authors
  1. Robert B. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert B. Taylor .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Taylor, R.B. (2011). Drug Interactions and Adventures in Polypharmacy. In: Essential Medical Facts Every Clinician Should Know. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7874-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-7874-5_11

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-7873-8

  • Online ISBN: 978-1-4419-7874-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation